SCHEMBL3344814

SCHEMBL3344814

CC(Cc1cc(C#N)c(N)s1)c1ccccn1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
GAA P10253 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
PLAUR Q03405 1/20 0.34
ALDH1A1 P00352 4/20 0.33
HPGD P15428 3/20 0.33
USP2 O75604 1/20 0.33
MAPT P10636 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
EGFR P00533 1/20 0.33
TSHR P16473 1/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3344813 0.75 GRIN2D (0.38) MEN1KMT2AGAASMN1; SMN2PLAUR
SCHEMBL3349055 0.75 CHRM2 (0.40) MEN1KMT2AGAASMN1; SMN2PLAUR
SCHEMBL3299360 0.75 L3MBTL1 (0.42) MEN1KMT2AGAASMN1; SMN2PLAUR
SCHEMBL9921703 0.67 SMN1; SMN2 (0.45) MEN1KMT2AGAASMN1; SMN2ALDH1A1
SCHEMBL4840749 0.66 GAA (0.41) MEN1KMT2AGAAALDH1A1HPGD
SCHEMBL11319209 0.66 CXCR4 (0.41) ALDH1A1TSHRCYP1A2CYP2D6KCNA5
SCHEMBL3301918 0.66 ADORA1 (0.46) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL3301341 0.66 ALDH1A1 (0.39) MEN1KMT2AGAASMN1; SMN2PLAUR
SCHEMBL25649146 0.66 MEN1 (0.35) MEN1KMT2AGAASMN1; SMN2MAPT
SCHEMBL3345196 0.65 MAOB (0.43) MEN1KMT2AGAASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010045015-A1 HETEROARYL SUBSTITUTED THIENO[2,3-D]PYRIMIDINE AND THEIR USE AS ADENOSINE A2A RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2010-04-22 WO disclosed